Erste Asset Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $732K | Hold |
|
|||||
|
2025
Q1 | $1.02M | Hold |
|
|||||
|
2024
Q4 | $1.37M | Hold |
|
|||||
|
2024
Q3 | $1.24M | Hold |
|
|||||
|
2024
Q2 | $1.74M | Hold |
|
|||||
|
2024
Q1 | $2.46M | Hold |
|
|||||
|
2023
Q4 | $2.64M | Buy |
|
|||||
|
2023
Q3 | $952K | Sell |
|
|||||
|
2023
Q2 | $4.6M | Buy |
|
|||||
|
2023
Q1 | $2.62M | Buy |
|
|||||
|
2022
Q4 | $1.91M | Hold |
|
|||||
|
2022
Q3 | $2.42M | Hold |
|
|||||
|
2022
Q2 | $1.67M | Hold |
|
|||||
|
2022
Q1 | $1.83M | Hold |
|
|||||
|
2021
Q4 | $1.75M | Buy |
|
|||||
|
2021
Q3 | $577K | Sell |
|
|||||
|
2021
Q2 | $2.15M | Hold |
|
|||||
|
2021
Q1 | $1.43M | Hold |
|
|||||
|
2020
Q4 | $1.86M | Buy |
|